NELSON TIMOTHY S
Insider CIK 1244229 · MAPP President and CEO, Director · IMPL Director · SRDX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| IMPLQ IPI Legacy Liquidation Co | J Other deriv | 2024-04-05 | 2024-04-09 | 11,500 | — | $0 | 0 | SEC↗ |
| IMPLQ IPI Legacy Liquidation Co | J Other deriv | 2024-04-05 | 2024-04-09 | 3,053 | — | $0 | 0 | SEC↗ |
| IMPLQ IPI Legacy Liquidation Co | J Other deriv | 2024-04-05 | 2024-04-09 | 22,325 | — | $0 | 0 | SEC↗ |
| IMPLQ IPI Legacy Liquidation Co | J Other deriv | 2024-04-05 | 2024-04-09 | 13,222 | — | $0 | 0 | SEC↗ |
| IMPLQ IPI Legacy Liquidation Co | J Other deriv | 2024-04-05 | 2024-04-09 | 12,789 | — | $0 | 0 | SEC↗ |
| IMPLQ IPI Legacy Liquidation Co | J Other deriv | 2024-04-05 | 2024-04-09 | 12,303 | — | $0 | 0 | SEC↗ |
| IMPLQ IPI Legacy Liquidation Co | J Other | 2024-04-05 | 2024-04-09 | 10,000 | — | $0 | 0 | SEC↗ |
| IMPL IMPEL PHARMACEUTICALS INC | A Award deriv | 2023-06-16 | 2023-06-20 | 13,222 | — | $0 | 13,222 | SEC↗ |
| IMPL IMPEL PHARMACEUTICALS INC | A Award deriv | 2022-06-16 | 2022-06-17 | 12,789 | — | $0 | 12,789 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | P Buy | 2021-11-19 | 2021-11-22 | 10,000 | $10.76 | $107.6K | 10,000 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | A Award deriv | 2021-07-11 | 2021-07-13 | 11,500 | — | $0 | 11,500 | SEC↗ |
| SRDX SURMODICS INC | A Award deriv | 2014-12-03 | 2014-12-05 | 4,430 | — | $0 | 4,430 | SEC↗ |
| SRDX SURMODICS INC | A Award | 2014-12-03 | 2014-12-05 | 1,118 | — | $0 | 6,176 | SEC↗ |
| SRDX SURMODICS INC | A Award deriv | 2014-02-17 | 2014-02-19 | 4,098 | — | $0 | 4,098 | SEC↗ |
| SRDX SURMODICS INC | A Award | 2014-02-17 | 2014-02-19 | 1,217 | — | $0 | 5,058 | SEC↗ |
| MAPP MAP Pharmaceuticals, Inc. | D To issuer deriv | 2013-03-01 | 2013-03-04 | 200,000 | — | $0 | 0 | SEC↗ |
| MAPP MAP Pharmaceuticals, Inc. | D To issuer deriv | 2013-03-01 | 2013-03-04 | 71,509 | — | $0 | 0 | SEC↗ |
| MAPP MAP Pharmaceuticals, Inc. | D To issuer deriv | 2013-03-01 | 2013-03-04 | 132,549 | — | $0 | 0 | SEC↗ |
| MAPP MAP Pharmaceuticals, Inc. | D To issuer deriv | 2013-03-01 | 2013-03-04 | 28,125 | — | $0 | 0 | SEC↗ |
| MAPP MAP Pharmaceuticals, Inc. | D To issuer deriv | 2013-03-01 | 2013-03-04 | 112,500 | — | $0 | 0 | SEC↗ |
| MAPP MAP Pharmaceuticals, Inc. | D To issuer deriv | 2013-03-01 | 2013-03-04 | 179,176 | — | $0 | 0 | SEC↗ |
| MAPP MAP Pharmaceuticals, Inc. | D To issuer deriv | 2013-03-01 | 2013-03-04 | 100,000 | — | $0 | 0 | SEC↗ |
| MAPP MAP Pharmaceuticals, Inc. | D To issuer deriv | 2013-03-01 | 2013-03-04 | 175,000 | — | $0 | 0 | SEC↗ |
| MAPP MAP Pharmaceuticals, Inc. | D To issuer deriv | 2013-03-01 | 2013-03-04 | 160,000 | — | $0 | 0 | SEC↗ |
| MAPP MAP Pharmaceuticals, Inc. | D To issuer deriv | 2013-03-01 | 2013-03-04 | 180,790 | — | $0 | 0 | SEC↗ |
| MAPP MAP Pharmaceuticals, Inc. | D To issuer deriv | 2013-03-01 | 2013-03-04 | 121,468 | — | $0 | 0 | SEC↗ |
| MAPP MAP Pharmaceuticals, Inc. | U Tender | 2013-03-01 | 2013-03-04 | 38,740 | $25.00 | $968.5K | 0 | SEC↗ |
| MAPP MAP Pharmaceuticals, Inc. | M Exercise deriv | 2013-01-25 | 2013-01-29 | 9,375 | — | $0 | 28,125 | SEC↗ |
| MAPP MAP Pharmaceuticals, Inc. | M Exercise | 2013-01-25 | 2013-01-29 | 9,375 | — | $0 | 42,392 | SEC↗ |
| MAPP MAP Pharmaceuticals, Inc. | F Tax w/h | 2013-01-25 | 2013-01-29 | 3,652 | $24.75 | $90.4K | 38,740 | SEC↗ |
| MAPP MAP Pharmaceuticals, Inc. | M Exercise deriv | 2013-01-23 | 2013-01-25 | 80,000 | — | $0 | 132,549 | SEC↗ |
| MAPP MAP Pharmaceuticals, Inc. | S Sale | 2013-01-23 | 2013-01-25 | 80,000 | $24.76 | $1.98M | 33,017 | SEC↗ |
| MAPP MAP Pharmaceuticals, Inc. | M Exercise | 2013-01-23 | 2013-01-25 | 80,000 | $0.64 | $51.2K | 113,017 | SEC↗ |
| MAPP MAP Pharmaceuticals, Inc. | A Award deriv | 2012-01-25 | 2012-01-27 | 37,500 | — | $0 | 37,500 | SEC↗ |
| MAPP MAP Pharmaceuticals, Inc. | A Award deriv | 2012-01-25 | 2012-01-27 | 112,500 | — | $0 | 112,500 | SEC↗ |